Genentech Patient Foundation Support offers two distinct programs: medication access assistance for patients prescribed eligible Genentech medicines, and funding for Independent Medical Education (IME) proposals. The patient assistance program helps individuals who cannot afford their medications access Genentech treatments at no cost.

The IME program supports educational initiatives for healthcare professionals aligned with Genentech's therapeutic areas. Award amounts vary based on program type and need. There is no fixed deadline listed.

Eligible applicants for IME grants include accredited medical education providers and academic medical centers. This opportunity is relevant for patient advocacy organizations, healthcare providers, and medical educators working in oncology, immunology, or other areas covered by Genentech's product portfolio.

Genentech: Requests for Proposals Attention: This page may not render properly. The browser you are using, Internet Explorer 10, is no longer supported. Important Notice: Due to our 2025 year-end close process, the Genentech Funding Request System will stop accepting charitable requests at 12:00 AM PT, November 27, 2025, and will reopen for requests on Friday, January 2, 2026.

Click here to learn more. Funding Request System Resources Contact Corporate Giving and Grants At Genentech, we believe philanthropy can be a powerful driver of change, particularly when aligned with our mission of improving the health and wellbeing of all patients, regardless of race, gender, or socioeconomic status.

In addition to funding requests we receive on a rolling basis throughout the year, which you can learn more about here , we periodically solicit proposals aligned to specific needs and objectives. Current / Open Opportunities Genentech is actively seeking applications for independent medical education. Click on the link below for more information and detailed instructions on submitting a Request for Proposal (RFP) application: NEW!

Independent Medical Education Request for Proposals - Spinal Muscular Atrophy Due to our 2023 year-end close process, the Genentech Funding Request System will stop accepting charitable requests at 12:00AM PT, Friday, November 24 and will reopen for requests on Tuesday, January 2, 2024.

This temporary closure affects Health, Patient, and Science Focused Giving, Education Focused Giving Graduate and Post-Graduate, Education Focused Giving K-12, and Community Giving. Independent Medical Education and the Independent Co-Payment Assistance Foundation will continue to accept requests during this time. The Genentech Foundation will only accept solicited requests during this time.

It is important to note the Genentech Funding Request System cannot accept requests less than 60 days prior to the event/program start date. Therefore, we will be unable to accept charitable contribution requests for an event or program occurring before March 2, 2024. Pending requests with event/program dates beginning in January 2024 or beyond may receive final decisions in the new year.

*Please note that our Funding Request System works best in Chrome and Safari Featured Fund: The Genentech Health Equity Innovation Fund Genentech launched the Health Equity Innovation Fund in 2019 to invest in bold, game-changing solutions with the potential to transform the healthcare system by eliminating deep-rooted health inequities.

By addressing unjust barriers that have prevented all patients, but especially patients of color, from benefiting equally from groundbreaking medical advances, the Innovation Fund is an important way that Genentech is advancing its ambitious Diversity & Inclusion goals.

The Innovation Fund prioritizes support for teams who have firsthand experience with the equity barriers their work addresses and can demonstrate principles of justice, diversity, equity and inclusion in their proposals. Since launching the Fund, Genentech has awarded $38 million to 89 grantees nationwide. We intend to award an additional $10 million to 10+ grantee partners through a fourth round of funding in 2024.

This will bring our total Innovation Fund investments to nearly $50 million in 100+ grantees since 2019. Learn more about the Innovation Fund and the impact of some of our prior grant recipients here. First & Last Name (required) Funding Process – What to Expect *Please note the funding process for RFPs may include additional steps.

1. Review Online Resources Click here for video tutorials, one-page tip sheets, and FAQs on how to use the funding request system. 2.

Submit Application via our Giving Portal You will receive a confirmation email upon submission. Your request will be reviewed for alignment to strategic focus areas and compliance with Genentech's policies 4. If Additional Information is Needed If we need more information to make a decision, you will receive a Request for Information (RFI), or hear from a team member directly.

You will be able to track the status of an application and will receive an email communication regarding the final decision. If approved, your organization will need to enter into a Letter of Agreement (LOA) with Genentech in order to receive funds.

*Please note that our Funding Request System works best in Chrome and Safari Genentech Patient Foundation Understanding Insurance and Coverage Medicine Information Support Our Focus on Neuroscience Our Focus on Ophthalmology CA Transparency in Supply For Medical Professionals Clinical Trial Information